Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3462)
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
200
Price
$104.25
Total Value
$20.85K
Shares Held After
58,117
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
2,300
Price
$103.44
Total Value
$237.91K
Shares Held After
58,317
% of Holdings
3.8%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
3,000
Price
$102.64
Total Value
$307.92K
Shares Held After
60,617
% of Holdings
4.7%
Jazz Pharmaceuticals plc (JAZZ)
Henderson Mary Elizabeth — SVP, Technical Operations
Shares
5,343
Price
$194.49
Total Value
$1.04M
Shares Held After
28,728
% of Holdings
15.7%
AbCellera Biologics Inc. (ABCL)
Thermopylae Holdings Ltd. — 10% Owner
Shares
177,457
Price
$3.27
Total Value
$580.28K
Shares Held After
56,096,097
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Apuli Maricel — Chief Accounting Officer
Shares
2,000
Price
$66.00
Total Value
$132.00K
Shares Held After
121,945
% of Holdings
1.6%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
15,294
Price
$15.00
Total Value
$229.41K
Shares Held After
61,867
% of Holdings
19.8%
Wave Life Sciences Ltd. (WVE)
Francis Chris — SVP, Corporate Development, Head of Emerging Areas
Shares
17,900
Price
$15.09
Total Value
$270.18K
Shares Held After
61,867
% of Holdings
22.4%
Axsome Therapeutics, Inc. (AXSM)
Coleman Mark — Director
Shares
25,000
Price
$161.11
Total Value
$4.03M
Shares Held After
47,140
% of Holdings
34.7%
Axsome Therapeutics, Inc. (AXSM)
Jacobson Mark L. — Chief Operating Officer
Shares
35,378
Price
$161.88
Total Value
$5.73M
Shares Held After
0
% of Holdings
100.0%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
16,313
Price
$7.01
Total Value
$114.29K
Shares Held After
154,657
% of Holdings
9.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
17,924
Price
$34.44
Total Value
$617.30K
Shares Held After
174,144
% of Holdings
9.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
165,408
Price
$33.63
Total Value
$5.56M
Shares Held After
477,783
% of Holdings
25.7%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Davis George Eric — EVP, Chief Legal Officer
Shares
26,061
Price
$61.36
Total Value
$1.60M
Shares Held After
72,453
% of Holdings
26.5%
BIOMARIN PHARMACEUTICAL INC (BMRN)
Friberg Gregory R — EVP, Chief R&D Officer
Shares
6,326
Price
$60.38
Total Value
$381.94K
Shares Held After
37,578
% of Holdings
14.4%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,638
Price
$276.32
Total Value
$728.92K
Shares Held After
85,096
% of Holdings
3.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
5,103
Price
$275.28
Total Value
$1.40M
Shares Held After
87,734
% of Holdings
5.5%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
12,378
Price
$23.86
Total Value
$295.34K
Shares Held After
639,076
% of Holdings
1.9%
Caribou Biosciences, Inc. (CRBU)
Kelly Timothy P — Chief Technology Officer
Shares
6,228
Price
$1.93
Total Value
$12.02K
Shares Held After
73,125
% of Holdings
7.8%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
523
Price
$18.04
Total Value
$9.43K
Shares Held After
209,641
% of Holdings
0.2%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
3,108
Price
$18.04
Total Value
$56.07K
Shares Held After
210,164
% of Holdings
1.5%
uniQure N.V. (QURE)
KLEMT CHRISTIAN — Chief Financial Officer
Shares
6,217
Price
$23.86
Total Value
$148.34K
Shares Held After
211,513
% of Holdings
2.9%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
942
Price
$28.90
Total Value
$27.22K
Shares Held After
170,273
% of Holdings
0.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
859
Price
$28.16
Total Value
$24.19K
Shares Held After
171,215
% of Holdings
0.5%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,437
Price
$26.98
Total Value
$38.77K
Shares Held After
172,074
% of Holdings
0.8%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
353
Price
$69.06
Total Value
$24.38K
Shares Held After
70,990
% of Holdings
0.5%
Q32 Bio Inc. (QTTB)
Kalowski Lee — CFO and President
Shares
3,995
Price
$4.51
Total Value
$18.04K
Shares Held After
35,943
% of Holdings
10.0%
Q32 Bio Inc. (QTTB)
Morrison Jodie Pope — Director
Shares
9,896
Price
$4.51
Total Value
$44.67K
Shares Held After
89,104
% of Holdings
10.0%
Q32 Bio Inc. (QTTB)
Violette Shelia M. — Chief Scientific Officer
Shares
2,815
Price
$4.51
Total Value
$12.71K
Shares Held After
55,569
% of Holdings
4.8%
Climb Bio, Inc. (CLYM)
Thomas Stephen Basil — Director
Shares
33,687
Price
$7.00
Total Value
$235.96K
Shares Held After
170,970
% of Holdings
16.5%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
2,000
Price
$1.49
Total Value
$2.98K
Shares Held After
1,906,186
% of Holdings
0.1%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
1,300
Price
$36.68
Total Value
$47.68K
Shares Held After
459,859
% of Holdings
0.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
10,436
Price
$35.96
Total Value
$375.28K
Shares Held After
461,159
% of Holdings
2.2%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
46,517
Price
$35.11
Total Value
$1.63M
Shares Held After
471,595
% of Holdings
9.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Sachdev Amit — EVP Chief Patient & Ext Af Off
Shares
1,846
Price
$486.35
Total Value
$897.80K
Shares Held After
55,570
% of Holdings
3.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
260
Price
$486.35
Total Value
$126.45K
Shares Held After
46,763
% of Holdings
0.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,410
Price
$489.00
Total Value
$1.18M
Shares Held After
17,559
% of Holdings
12.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
McKechnie Duncan — EVP, Chief Commercial Officer
Shares
2,500
Price
$486.35
Total Value
$1.22M
Shares Held After
19,969
% of Holdings
11.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
700
Price
$275.00
Total Value
$192.50K
Shares Held After
92,837
% of Holdings
0.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
223
Price
$486.35
Total Value
$108.46K
Shares Held After
6,981
% of Holdings
3.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
945
Price
$486.35
Total Value
$459.60K
Shares Held After
13,659
% of Holdings
6.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
668
Price
$486.35
Total Value
$324.88K
Shares Held After
18,432
% of Holdings
3.5%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
11,219
Price
$113.82
Total Value
$1.28M
Shares Held After
33,938
% of Holdings
24.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
8
Price
$93.49
Total Value
$747.92
Shares Held After
666,195
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
1,501
Price
$92.81
Total Value
$139.31K
Shares Held After
666,203
% of Holdings
0.2%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
3,293
Price
$91.76
Total Value
$302.17K
Shares Held After
667,704
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
5,434
Price
$90.39
Total Value
$491.18K
Shares Held After
670,997
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
19,764
Price
$89.78
Total Value
$1.77M
Shares Held After
676,431
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
CAUSEY CHRISTOPHER — Director
Shares
1,000
Price
$520.00
Total Value
$520.00K
Shares Held After
4,190
% of Holdings
19.3%
NewAmsterdam Pharma Co N.V. (NAMS)
Davidson Michael H. — Director
Shares
3,161
Price
$36.46
Total Value
$115.25K
Shares Held After
459,859
% of Holdings
0.7%
Showing 1951–2000 of 3462 transactions (page 40 of 70)